Jim Simons acquired 33k Vor Biopharma shares worth $664k. That's 0.00% of their equity portfolio (2322nd largest holding). The first Vor Biopharma trade was made in Q2 2022. Since then Jim Simons bought shares ten more times and sold shares on six occasions. The stake costed the investor $468k, netting the investor a gain of 42% so far.